Fig. 3: Subgroup analysis in the intention-to-treat population. | Nature Communications

Fig. 3: Subgroup analysis in the intention-to-treat population.

From: Final survival analysis of induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma: a multicenter, randomized, phase 3 trial

Fig. 3: Subgroup analysis in the intention-to-treat population.

A Progression-free Survival, B Overall Survival, C Locoregional Recurrence-free Survival, D Distant Metastasis-free Survival. An unstratified Cox proportional hazards model was used to calculate HRs and 95% CIs, and to execute the interaction test. HR hazard ratio. EBV-DNA Epstein-Barr virus DNA. 1 = Sun Yat-sen University Cancer Center. 2 = Other hospitals.

Back to article page